医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ニュース
添付文書
薬の臨床実感＆助言集
▼×

遺伝学

Genome Editing Biotech Company EdiGene Raises $15 Million in Series pre-B Financing

Genome Editing Biotech Company EdiGene Raises $15 Million in Series pre-B Financing

バイオテクノロジーヘルスケア製薬遺伝学　 TimeLine: Genome Editing Biotech Company EdiGene Raises pre-B Financing

2018年08月08日

0

Ambys Medicines and Takeda Announce Partnership to Pioneer First-in-Class Therapies for the Treatment of Serious Liver Diseases

Ambys Medicines and Takeda Announce Partnership to Pioneer First-in-Class Therapies for the Treatment of Serious Liver Diseases

バイオテクノロジーヘルスケアヘルス一般製薬遺伝学　 TimeLine: Ambys Medicines and Takeda Announce Partnership First-in-Class Therapies for the Treatment

2018年08月08日

0

Genome Editing Biotech EdiGene Names Dong Wei, Ph.D., MBA as its Chief Executive Officer

Genome Editing Biotech EdiGene Names Dong Wei, Ph.D., MBA as its Chief Executive Officer

バイオテクノロジーヘルスケア製薬遺伝学　 TimeLine: Genome Editing Biotech EdiGene Names Dong Wei MBA as its Chief

2018年08月02日

0

NeuroVia Initiates Phase 1/2 Trial of NV1205 for Treating Childhood Cerebral Adrenoleukodystrophy (CCALD)

NeuroVia Initiates Phase 1/2 Trial of NV1205 for Treating Childhood Cerebral Adrenoleukodystrophy (CCALD)

バイオテクノロジーヘルスケア臨床試験製薬遺伝学　 TimeLine: 2 Trial of NV1205 for Treating Childhood Cerebral Adrenoleukodystrophy NeuroVia Initiates Phase 1

2018年07月25日

0

Quantapore Inc. Closes Series 3 Financing Round to Fund Beta Launch of DNA Sequencer

Quantapore Inc. Closes Series 3 Financing Round to Fund Beta Launch of DNA Sequencer

バイオテクノロジーヘルスケア遺伝学　 TimeLine: Closes Series 3 Financing Round to Fund DNA Sequencer Quantapore Inc

2018年07月19日

0

Sonic Healthcare Selects Translational Software’s Pharmacogenomics Platform to Advance Precision Medicine in Australia

Sonic Healthcare Selects Translational Software’s Pharmacogenomics Platform to Advance Precision Medicine in Australia

バイオテクノロジーヘルスケア医療管理臨床試験製薬遺伝学　 TimeLine: Platform to Advance Precision Medicine Sonic Healthcare Selects Translational Software's

2018年07月10日

0

JPND and NIH Awards to Support New Transatlantic Collaborations

JPND and NIH Awards to Support New Transatlantic Collaborations

ヘルスケアメンタルヘルス医療機器製薬遺伝学　 TimeLine: JPND and NIH Awards to Support New

2018年07月05日

0

Alteogen and Lynkogen Enter into an Exclusive Option Agreement to Develop Proprietary Fusion Proteins for the Treatment of NASH and Metabolic Diseases

Alteogen and Lynkogen Enter into an Exclusive Option Agreement to Develop Proprietary Fusion Proteins for the Treatment of NASH and Metabolic Diseases

バイオテクノロジーヘルスケア製薬遺伝学　 TimeLine: Alteogen and Lynkogen Enter into an Exclusive Develop Proprietary Fusion Proteins for the Metabolic Diseases

2018年07月01日

0

Japanese Patent Office Grants Broad Claims Covering CRISPR/Cas9 Gene Editing Technology

Japanese Patent Office Grants Broad Claims Covering CRISPR/Cas9 Gene Editing Technology

バイオテクノロジーヘルスケア製薬遺伝学　 TimeLine: Cas9 Gene Editing Technology Japanese Patent Office Grants Broad Claims

2018年06月15日

0

Emmanuelle Charpentier博士らのCRISPR/Cas9技術基本特許：日本において成立

Emmanuelle Charpentier博士らのCRISPR/Cas9技術基本特許：日本において成立

バイオテクノロジーヘルスケア製薬遺伝学　 TimeLine: Cas9技術基本特許 CRISPR Emmanuelle Charpentier博士ら

2018年06月15日

0